Open AccessSurvey to Specify SGLT2 Inhibitor Choice in T2DM Management
Author(s) -
Samit Ghosal,
Radhika M. Joshi,
Rahul N. Iyer,
Samir M. Adsule
Publication year - 2022
Publication title -
clinical diabetology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.152
H-Index - 4
eISSN - 2450-8187
pISSN - 2450-7458
DOI - 10.5603/dk.a2022.0042
Subject(s) - empagliflozin , canagliflozin , dapagliflozin , medicine , glycemic , intensive care medicine , medical prescription , type 2 diabetes mellitus , family medicine , diabetes mellitus , pharmacology , insulin , endocrinology